Skip to main content
. Author manuscript; available in PMC: 2017 Jun 26.
Published in final edited form as: J Pain Symptom Manage. 2015 Sep 3;51(1):79–87.e1. doi: 10.1016/j.jpainsymman.2015.08.003

Table 3.

Event rates in drug exposure categories including methadone, hydromorphone, morphine and fentanyl. All opioid doses are adjusted and reported as their equivalent in oral methadone.

Methadone Hydromorphone
Days Exposed % Days With Hypoglycemia 95% CI Days Exposed % Days With Hypoglycemia 95% CI

Oral 0-15 mg equivalent 1033 3.9 (2.9-5.2) 1103 3.8 (2.8-5.1)
Oral 15-40 mg equivalent 1883 4.2 (3.4-5.2) 72 4.2 (1.4-11.5)
Oral 40-80 mg equivalent 1827 7.4 (6.3-8.7) 0
Oral > 80 equivalent 1761 8.0 (6.8-9.3) 1 0.0 (0.0-94.9)

IV 0-15 mg equivalent 314 5.7 (3.7-8.9) 1995 5.0 (4.1-6.1)
IV 15-40 mg equivalent 498 5.6 (3.9-8.0) 562 5.2 (3.6-7.3)
IV 40-80 mg equivalent 349 12.6 (9.5-16.5) 188 6.4 (3.7-10.8)
IV > 80 mg equivalent 345 13.0 (9.9-17.0) 106 2.8 (1.0-8.0)

PCA 542 16.4 (13.5-19.8) 2375 4.7 (3.9-5.6)

Morphine Fentanyl
Days Exposed % Days With Hypoglycemia 95% CI Days Exposed % Days With Hypoglycemia 95% CI

Oral 0-15 mg equivalent 297 5.1 (3.1-8.2) 0
Oral 15-40 mg equivalent 56 1.8 (0.1-9.4) 1 0.0 (0.0-94.9)
Oral 40-80 mg equivalent 37 0.0 (0.0-9.4) 6 0.0 (0.0-39.0)
Oral > 80 equivalent 43 0.0 (0.0-8.2) 27 3.7 (0.2-18.3)

IV 0-15 mg equivalent 710 5.1 (3.7-6.9) 102 7.8 (4.0-14.7)
IV 15-40 mg equivalent 33 18.2 (8.6-34.4) 227 4.8 (2.7-8.5)
IV 40-80 mg equivalent 2 0.0 (0.0-65.8) 345 2.0 (1.0-4.1)
IV > 80 mg equivalent 0 948 2.8 (2.0-4.1)

PCA 575 5.2 (3.7-7.4) 2241 3.1 (2.4-3.9)

Transdermal 1236 2.3 (1.6-3.3)